rawfin.tv
FDA Places Clinical Hold on Aardvark Therapeutics' IND, Company to Unblind Data
Regulationstocks🟠 Score 8AI Generated

FDA Places Clinical Hold on Aardvark Therapeutics' IND, Company to Unblind Data

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

The FDA has issued a full clinical hold on Aardvark Therapeutics' investigational new drug application. In response, Aardvark Therapeutics plans to unblind data from its HERO and OLE studies to determine the path forward for its drug candidate.

clinical-holddrug-developmentbiotechFDA-regulation

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks